Chemistry:M-ALPHA
M-ALPHA, also known as 3,4-methylenedioxy-α-ethyl-N-methylbenzylamine or as α-ethyl-N-methylpiperonylamine, is a psychoactive drug of the substituted benzylamine group.[1][2] It was reported by Alexander Shulgin in his book PIHKAL as a positional isomer of MDMA.[1][2] Subsequently, the drug was encountered as a designer drug in the United Kingdom in 2010 and was reported to the EMCDDA new drug monitoring service.[3] It was described by Shulgin as similar in action to its demethylated homologue, ALPHA, but with roughly twice the duration and twice the potency.[1] ALPHA itself was described as active at doses of 10 to 140 mg, with a duration of about 3 hours, and producing eyes-closed "dreams", some body tingling, and a pleasant positive feeling, but without any appetite suppression.[1] M-ALPHA was encountered as a designer drug by 2010.[4]
See also
- ALPHA
- MDM1EA
- Methylenedioxybenzylpiperazine (MDBZP)
- Filenadol
- Isoethcathinone
- Methylenedioxyphencyclidine
- M-α-HMCA
- Homo-MDA
- Homo-MDMA
- UC-514321
References
- ↑ 1.0 1.1 1.2 1.3 Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. http://www.erowid.org/library/books_online/pihkal/pihkal.shtml.
- ↑ 2.0 2.1 The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. 1. Berkeley: Transform Press. 2011. ISBN 978-0-9630096-3-0.
- ↑ "EMCDDA Annual Report 2010". http://www.emcdda.europa.eu/attachements.cfm/att_132857_EN_EMCDDA-Europol%20Annual%20Report%202010A.pdf.
- ↑ "EMCDDA–Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA". 2 July 2024. https://www.euda.europa.eu/publications/implementation-reports/2010_en.
External links
 |  |
